Quantitation of tazemetostat in human plasma using liquid chromatography–tandem mass spectrometry

Documenti analoghi

• Quantitation of the DNA‐dependent protein kinase inhibitor peposertib (M3814) and metabolite in human plasma by LC–MS/MS
  di: Susan M. Christner, et al.
  Pubblicazione: (2024)
• Quantitation of Niraparib in Human Plasma by LC‐MS/MS
  di: Tien V. Le, et al.
  Pubblicazione: (2025)
• Liquid chromatography–tandem mass spectrometry determination of bumetanide in human plasma and application to a clinical pharmacokinetic study
  di: Ganesan Padmini Tamilarasi, et al.
  Pubblicazione: (2024)
• Simultaneous determination of four fungicide residues in figs using liquid chromatography tandem mass spectrometry
  di: Feng Lan, et al.
  Pubblicazione: (2024)
• Pharmacokinetics of IMM‐H012 in rats using ultra‐performance liquid chromatography‐tandem mass spectrometry
  di: Shujuan Wu, et al.
  Pubblicazione: (2024)